• Ruxolitinib

    "Ruxolitinib"

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    "Ruxolitinib" Myelofibrosis Novartis La 6 Phupu 2024
  • Relugolix

    Relugolix

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Relugolix Kankere ea tšoelesa ea senya Takeda le ASKA La 24 Pherekhong 2024
  • Rimegepant

    Rimegepant

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Rimegepant Hlooho ea Migraine Biohaven Hlakola 22, 2031

     

  • Relugolix 737789-87-6

    Relugolix 737789-87-6

    Lebitso la API Pontsho Tlhaloso US DMF EU DMF CEP
    Ribociclib CAS: 737789-87-6 Antineoplastic Ka Ntlong      
  • Ribociclib 1374639-75-4

    Ribociclib 1374639-75-4

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Ribociclib 1374639-75-4 HR-positive, HER2-negative Andvance ormetastaticbreast Cancers Novartis
    Meriana ea meriana
    Phup.27, 2028
  • Rivaroxaban

    Rivaroxaban

    Lebitso la API Pontsho Tlhaloso US DMF EU DMF CEP
    Rivaroxaban Anticoagulant Ka Ntlong TDP    
  • Rosuvastatin Calcium

    Calcium ea Rosuvastatin

    Lebitso la API Pontsho Tlhaloso US DMF EU DMF CEP
    Calcium ea Rosuvastatin Hypercholesterolemia Ka Ntlong/CEP 20705 CEP2015-240